CN112999285A - 一种固本抗衰口服液配方及其制备方法 - Google Patents
一种固本抗衰口服液配方及其制备方法 Download PDFInfo
- Publication number
- CN112999285A CN112999285A CN202110290795.4A CN202110290795A CN112999285A CN 112999285 A CN112999285 A CN 112999285A CN 202110290795 A CN202110290795 A CN 202110290795A CN 112999285 A CN112999285 A CN 112999285A
- Authority
- CN
- China
- Prior art keywords
- parts
- liquid
- oral liquid
- ginseng
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 46
- 238000005728 strengthening Methods 0.000 title claims abstract description 12
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 238000009472 formulation Methods 0.000 title description 2
- 238000000855 fermentation Methods 0.000 claims abstract description 23
- 230000004151 fermentation Effects 0.000 claims abstract description 23
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 16
- 238000001914 filtration Methods 0.000 claims abstract description 16
- 238000005303 weighing Methods 0.000 claims abstract description 11
- 240000007371 Cuscuta campestris Species 0.000 claims abstract description 8
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 8
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 8
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 8
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 8
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 8
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 8
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 8
- 210000003056 antler Anatomy 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 235000008434 ginseng Nutrition 0.000 claims abstract description 8
- 210000002826 placenta Anatomy 0.000 claims abstract description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 7
- 235000011477 liquorice Nutrition 0.000 claims abstract description 7
- 241000173529 Aconitum napellus Species 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 14
- 230000032683 aging Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 241000186000 Bifidobacterium Species 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 239000012669 liquid formulation Substances 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 206010016256 fatigue Diseases 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 241000227129 Aconitum Species 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 206010034568 Peripheral coldness Diseases 0.000 description 4
- 206010062519 Poor quality sleep Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 2
- 208000032140 Sleepiness Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000037321 sleepiness Effects 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Anesthesiology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
Abstract
本发明公开了一种固本抗衰口服液配方及其制备方法，涉及日常保健领域，是由红参12‑18份，干参12‑18份，鹿茸8‑12份，紫河车10‑14份，制附子8‑12份，枸杞子15‑25份，酒菟丝子25‑35份，盐故子25‑35份，甘草8‑12份，三七12‑18份经称取、制液、一次发酵、过滤、二次发酵和分装步骤制成，本发明的有益效果在于，使用本发明提出的固本抗衰口服液能有效地的健肾补气，可有效地缓解人们因日常生活中的不良生活习惯和作息规律所引起的腰酸乏力，精神不振等不良身体症状，提高了人们的日常工作生活质量。
Description
技术领域
本发明涉及日常保健领域，具体是涉及一种固本抗衰口服液配方及其制备方法。
背景技术
改革开放以来，随着经济的高速发展，社会竞争的日趋激烈，人们生活节奏的加快和工作压力的增大而导致的亚健康问题日渐普遍。据有关调查，目前我国约有七成人处于亚健康状态，严重影响了人们的身体健康和生活质量。
造成人们亚健康的原因主要为不规律的作息和不健康的生活方式所导致的肾虚气弱、肝脾两伤，从而导致免疫力下降，腰酸乏力、皮肤暗淡、记忆力下降、精神不振、头发掉落、睡眠不好等各种身体亚健康症状，服用具有健肾补气，补脾健肝的保健品可有效缓解因肾虚气弱所导致的亚健康症状。
发明内容
为解决上述技术问题，提供一种固本抗衰口服液配方及其制备方法，本技术方案可有效缓解因不规律的作息和不健康的生活方式所导致的肾虚气弱、肝脾两伤，所带来的免疫力下降，腰酸乏力、皮肤暗淡、记忆力下降、精神不振、头发掉落、睡眠不好等各种身体亚健康症状。
为达到以上目的，本发明提供一种固本抗衰口服液配方，由如下重量份数的组分组成：
红参12-18份，干参12-18份，鹿茸8-12份，紫河车10-14份，制附子8-12份，枸杞子15-25份，酒菟丝子25-35份，盐故子25-35份，甘草8-12份，三七12-18份。
优选的，一种固本抗衰液配方，由如下重量份数的组分组成：
红参15份，干参15份，鹿茸10份，紫河车12份，制附子10份，枸杞子20份，酒菟丝子30份，盐故子30份，甘草10份，三七15份。
可选的，一种固本抗衰口服液配方的制备方法，其特征在于，包括以下步骤：
S1.称取：按重量配比计量称取对应重量的中药药材；
S2.制液：将S1中称取的中药药材粉碎成中号粉，使用90-100℃开水浸振60-90分钟得到药渣混合液；
S3.一次发酵：将S2中得到的药渣混合液自放降温至30℃左右加入菌种，将加入菌种的药渣混合液输入到发酵器皿中控温25-35℃静置发酵30天；
S4.过滤：对S3中进行发酵后的药渣混合液进行过滤，去除其中的药渣得到药液；
S5.二次发酵：向S4中得到的药液中以1:10的比例加入菌种，进行控温25-35℃静置发酵30天；
S6..分装：对S5中进行二次发酵得到的药液进行过滤后，按照一次服用剂量进行密封包装备用。
可选的，一种固本抗衰口服液的制备方法，所述S3和S5中加入的菌种为乳酸菌和双歧杆菌中任意一种。
本发明中各组分的药理作用如下:
红参：大补元气、益气、复脉固脱；
干参：调整血压、恢复心脏功能、神经衰弱及身体虚弱；
鹿茸：补肾壮阳，生精益血，补髓健骨；
紫河车：味甘、咸，性温，能补肾益精，补气益血；
制附子：回阳救逆，补火助阳，逐风寒湿邪，用于亡阳虚脱，肢冷脉微，阳痿，宫冷，心腹冷痛，虚寒吐泻，阴寒水肿，阳虚外感，寒湿痹痛；
枸杞子：滋肾，润肺，补肝，明目；
酒菟丝子：补益肝肾，固精缩尿，安胎，明目，止泻；
盐故子：补肾壮阳,固精缩尿,温脾止泻；
甘草：补脾益气，清热解毒，祛痰止咳，缓急止痛；
三七：化瘀止血，活血定痛。
本发明的有益效果在于：本发明所提出的一种固本抗衰口服液根据传统中医理论和治疗用药的基本原则，在丰富的中药中筛选而出的对肾脏、脾脏和肝脏具有良好补益效果的中药材根据传统中医理论中的“君臣佐和”进行成分配比，通过使用益生菌发酵代替传统中药制备中的煎、熬以及生药材粉碎制药的方法，使得药材中的有效成分可迅速被人体充分吸收进而达到减少药量，降低副作用的效果，使用本发明提出的固本抗衰口服液可有效地补肾益气、健脾壮肝，从而极大的缓解了当代人们因为生活压力大，作息不规律，生活方式不健康所导致的免疫力下降，腰酸乏力、皮肤暗淡、记忆力下降、精神不振、头发掉落、睡眠不好等各种身体亚健康症状。
具体实施方法
基于上述发明内容的具体中药组分以及制备方法和使用方法，下面举例说明本发明中固本抗衰口服液配方及其制备方法的具体实施方法
实施例一：
一种固本抗衰口服液配方，由如下重量份数的组分组成:
红参12份，干参12份，鹿茸8份，紫河车10份，制附子8份，枸杞子15份，酒菟丝子25份，盐故子25份，甘草8份，三七12份；
其制备方法如下：
S1.称取：按重量配比计量称取对应重量的中药药材；
S2.制液：将S1中称取的中药药材粉碎成中号粉，使用90-100℃开水浸振60-90分钟得到药渣混合液；
S3.一次发酵：将S2中得到的药渣混合液自放降温至30℃左右加入菌种，将加入菌种的药渣混合液输入到发酵器皿中控温25-35℃静置发酵30天；
S4.过滤：对S3中进行发酵后的药渣混合液进行过滤，去除其中的药渣得到药液；
S5.二次发酵：向S4中得到的药液中以1:10的比例加入菌种，进行控温25-35℃静置发酵30天；
S6.分装：对S5中进行二次发酵得到的药液进行过滤后，按照一次服用剂量进行密封包装备用。
具体使用案例：何某，男，25岁，武汉市洪山区，学生，因长期不规律、不健康的生活方式导致肾虚脾弱，出现记忆力下降、注意力无法集中、精神不振、头发掉落、尿频等症状，在使用本实施例所配出的固本抗衰口服液一周后记忆力下降、精神不振等症状出现明显改善，在使用一月后身体恢复健康，身体的各种不良症状基本消失，学习生活质量提高。
实施例二：
一种固本抗衰口服液配方，由如下重量份数的组分组成:
红参18份，干参18份，鹿茸12份，紫河车14份，制附子12份，枸杞子25份，酒菟丝子35份，盐故子35份，甘草12份，三七18份；
其制备方法如下：
S1.称取：按重量配比计量称取对应重量的中药药材；
S2.制液：将S1中称取的中药药材粉碎成中号粉，使用90-100℃开水浸振60-90分钟得到药渣混合液；
S3.一次发酵：将S2中得到的药渣混合液自放降温至30℃左右加入菌种，将加入菌种的药渣混合液输入到发酵器皿中控温25-35℃静置发酵30天；
S4.过滤：对S3中进行发酵后的药渣混合液进行过滤，去除其中的药渣得到药液；
S5.二次发酵：向S4中得到的药液中以1:10的比例加入菌种，进行控温25-35℃静置发酵30天；
S6.分装：对S5中进行二次发酵得到的药液进行过滤后，按照一次服用剂量进行密封包装备用。
具体实施案例：王某，52岁，承德市双桥区，办公室文职，长期久坐，家庭负担重，生活压力大，随着年龄的增大导致身体肾虚脾弱，精气衰弱，身体出现腰酸乏力、皮肤暗淡、精神不振、头发掉落、睡眠不好等症状，在使用本实施例所配出的固本抗衰口服液一月后皮肤暗淡，腰酸乏力等症状得到有效改善，在使用两月后皮肤红润，睡眠良好，身体的各项不良症状基本消失，工作生活质量提高。
实施例三：
一种固本抗衰口服液配方，由如下重量份数的组分组成:
红参15份，干参15份，鹿茸10份，紫河车12份，制附子10份，枸杞子20份，酒菟丝子30份，盐故子30份，甘草10份，三七15份；
其制备方法如下：
S1.称取：按重量配比计量称取对应重量的中药药材；
S2.制液：将S1中称取的中药药材粉碎成中号粉，使用90-100℃开水浸振60-90分钟得到药渣混合液；
S3.一次发酵：将S2中得到的药渣混合液自放降温至30℃左右加入菌种，将加入菌种的药渣混合液输入到发酵器皿中控温25-35℃静置发酵30天；
S4.过滤：对S3中进行发酵后的药渣混合液进行过滤，去除其中的药渣得到药液；
S5.二次发酵：向S4中得到的药液中以1:10的比例加入菌种，进行控温25-35℃静置发酵30天；
S6.分装：对S5中进行二次发酵得到的药液进行过滤后，按照一次服用剂量进行密封包装备用。
具体实施案例：钱某，女，39岁，襄阳市谷城县，自由职业，在一次骑电动车过程中摔倒不幸撞击到腰部导致肾脏受损，经治疗后元气大伤，身体出现手脚冰凉、皮肤暗淡、精神不振、日常生活中经常出现犯困、睡眠中出现盗汗等症状，在使用本实施例所配出的固本抗衰口服液两周后皮肤暗淡、手脚冰凉、日常生活中经常出现犯困、睡眠中出现盗汗等症状得到有效缓解，在使用六周之后皮肤红润，身体的各项不良症状基本消失，生活质量提高。
综上所述，本发明的有益效果在于，使用本发明提出的固本抗衰口服液能有效地的健肾补气，有效地缓解人们因日常生活中的不良生活习惯和作息规律所引起的腰酸乏力，精神不振等不良身体症状，提高了人们的日常工作生活质量。
以上显示和描述了本发明的基本原理、主要特征和本发明的优点。本行业的技术人员应该了解，本发明不受上述实施例的限制，上述实施例和说明书中描述的只是本发明的原理，在不脱离本发明精神和范围的前提下本发明还会有各种变化和改进，这些变化和改进都落入要求保护的本发明的范围内。本发明要求的保护范围由所附的权利要求书及其等同物界定。
Claims (3)
1.一种固本抗衰口服液配方，其特征在于，有如下重量份数的组分组成：
红参12-18份，干参12-18份，鹿茸8-12份，紫河车10-14份，制附子8-12份，枸杞子15-25份，酒菟丝子25-35份，盐故子25-35份，甘草8-12份，三七12-18份。
2.一种根据权利要求1所述的一种固本抗衰口服液配方的制备方法，其特征在于，包括以下步骤：
S1.称取：按重量配比计量称取对应重量的中药药材；
S2.制液：将S1中称取的中药药材粉碎成中号粉，使用90-100℃开水浸振60-90分钟得到药渣混合液；
S3.一次发酵：将S2中得到的药渣混合液自放降温至30℃左右加入菌种，将加入菌种的药渣混合液输入到发酵器皿中控温25-35℃静置发酵30天；
S4.过滤：对S3中进行发酵后的药渣混合液进行过滤，去除其中的药渣得到药液；
S5.二次发酵：向S4中得到的药液中以1:10的比例加入菌种，进行控温25-35℃静置发酵30天；
S6.分装：对S5中进行二次发酵得到的药液进行过滤后，按照一次服用剂量进行密封包装备用。
3.根据权利要求2所述的一种固本抗衰口服液的制备方法，其特征在于，所述S3和S5中加入的菌种为乳酸菌和双歧杆菌中任意一种。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110290795.4A CN112999285A (zh) | 2021-03-18 | 2021-03-18 | 一种固本抗衰口服液配方及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110290795.4A CN112999285A (zh) | 2021-03-18 | 2021-03-18 | 一种固本抗衰口服液配方及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112999285A true CN112999285A (zh) | 2021-06-22 |
Family
ID=76409649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110290795.4A Pending CN112999285A (zh) | 2021-03-18 | 2021-03-18 | 一种固本抗衰口服液配方及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112999285A (zh) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102250736A (zh) * | 2011-06-16 | 2011-11-23 | 牟一心 | 一种保健药酒及其制造方法 |
-
2021
- 2021-03-18 CN CN202110290795.4A patent/CN112999285A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102250736A (zh) * | 2011-06-16 | 2011-11-23 | 牟一心 | 一种保健药酒及其制造方法 |
Non-Patent Citations (2)
| Title |
|---|
| 李可: "《李可老中医急危重症疑难病经验专辑》", 31 March 2005, 山西科学技术出版社 * |
| 王静涵等: "益生菌发酵中药的研究现状及产品开发", 《食品工业科技》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102283999B (zh) | 一种治疗失眠的中药制剂 | |
| CN102579708B (zh) | 一种壮阳补肾健肝肺的中药 | |
| CN103316145B (zh) | 一种治疗下肢胀痛的中药泡脚液及制备方法 | |
| CN107007724B (zh) | 一种中药保健液及其制备方法 | |
| CN105641466A (zh) | 一种补肾壮阳的中药组合物及其制备方法 | |
| CN105194316A (zh) | 一种补肾壮阳增强免疫力的药酒 | |
| CN104547778A (zh) | 一种用于超声科防辐射的中药制剂及制备方法 | |
| CN109674912A (zh) | 一种调理痰湿体质的中药泡浴抑菌液/颗粒及制备与使用方法 | |
| CN112999285A (zh) | 一种固本抗衰口服液配方及其制备方法 | |
| CN103550521A (zh) | 一种治疗盗汗的中药组合物 | |
| CN103432426B (zh) | 一种治疗神经性肌肉萎缩的中药片剂及其制备方法 | |
| CN103520289B (zh) | 一种治疗便秘的中药组合物及其制备方法和应用 | |
| CN111265609A (zh) | 一种辅助治疗真性近视的中药组合物及其制备方法 | |
| CN104147156A (zh) | 一种含有补肾中药组合物的饮料及其制备方法 | |
| CN103463463A (zh) | 一种补血活血、祛风除湿的中药制剂 | |
| CN103285243B (zh) | 治疗高血糖的冲剂 | |
| CN103386017B (zh) | 一种滋肾填精的杞润氨基酸口服液及其制备工艺 | |
| CN107375851A (zh) | 用于治疗局限性硬皮病的药物 | |
| CN107335034A (zh) | 一种治疗白癜风的外用中药组合物及其应用 | |
| CN105878627A (zh) | 一种治疗近视眼病的中药配方 | |
| CN104922454A (zh) | 一种治疗软组织挫伤的内服药物及其制备方法 | |
| CN107115410B (zh) | 一种中药泡浴配方、制备方法及使用方法 | |
| CN105617388A (zh) | 一种补肾壮阳的药物组合物 | |
| CN108542985A (zh) | 一种男性壮阳生精保健酒药的配制方法 | |
| CN104147396A (zh) | 一种治疗神经性肌肉萎缩中药片剂的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210622 |